Omacor and Arteriosclerosis coronary artery - a phase IV clinical study of FDA data

Summary:

Arteriosclerosis coronary artery is found among people who take Omacor, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Omacor and have Arteriosclerosis coronary artery. It is created by eHealthMe based on reports of 2,404 people who have side effects when taking Omacor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

2,404 people reported to have side effects when taking Omacor.
Among them, 17 people (0.71%) have Arteriosclerosis coronary artery.


What is Omacor?

Omacor has active ingredients of omega-3acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 2,443 Omacor users for its effectiveness, alternative drugs and more.

What is Arteriosclerosis coronary artery?

Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery) is found to be associated with 1,327 drugs and 807 conditions by eHealthMe.

Number of Omacor and Arteriosclerosis coronary artery reports submitted per year:

Could Omacor cause Arteriosclerosis coronary artery?

Time on Omacor when people have Arteriosclerosis coronary artery *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Arteriosclerosis coronary artery when taking Omacor *:

  • female: 11.76 %
  • male: 88.24 %

Age of people who have Arteriosclerosis coronary artery when taking Omacor *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 6.67 %
  • 50-59: 0.0 %
  • 60+: 93.33 %

Common drugs people take besides Omacor *:

  1. Tasigna: 8 people, 47.06%
  2. Captopril: 7 people, 41.18%
  3. Torsemide: 7 people, 41.18%
  4. Acetylsalicylic Acid: 4 people, 23.53%
  5. Plavix: 3 people, 17.65%
  6. Amlodipine: 2 people, 11.76%
  7. Antara: 2 people, 11.76%
  8. Fortical: 2 people, 11.76%
  9. Folic Acid: 2 people, 11.76%
  10. Fluoxetine: 2 people, 11.76%

Common side effects people have besides Arteriosclerosis coronary artery *:

  1. Coronary Artery Stenosis (narrowing of coronary artery): 13 people, 76.47%
  2. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 12 people, 70.59%
  3. Chest Pain: 12 people, 70.59%
  4. Femoral Arterial Stenosis (narrowing of artery of femur bone): 11 people, 64.71%
  5. Stable Angina (a constant chest pain): 11 people, 64.71%
  6. Ventricular Fibrillation (abnormally irregular heart rhythm): 11 people, 64.71%
  7. Gait Disturbance: 10 people, 58.82%
  8. Aortic Arteriosclerosis (hardening of the aortic arteries): 10 people, 58.82%
  9. Atherosclerosis (disorder of the arteries): 10 people, 58.82%
  10. Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 10 people, 58.82%

Common conditions people have *:

  1. High Blood Pressure: 12 people, 70.59%
  2. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 12 people, 70.59%
  3. Ventricular Extrasystoles (premature cardiac contraction): 11 people, 64.71%
  4. Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 11 people, 64.71%
  5. Heart Attack: 2 people, 11.76%
  6. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 5.88%
  7. Stable Angina (a constant chest pain): 1 person, 5.88%
  8. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.88%
  9. Magnesium Deficiency (lack of magnesium): 1 person, 5.88%
  10. Diabetes: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Omacor and have Arteriosclerosis coronary artery?

Check whether Arteriosclerosis coronary artery is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Omacor:

Arteriosclerosis coronary artery treatments and more:

COVID vaccines that are related to Arteriosclerosis coronary artery:

How severe was Arteriosclerosis coronary artery and when was it recovered:

Expand to all the drugs that have ingredients of omega-3acid ethyl esters:

Common drugs associated with Arteriosclerosis coronary artery:

All the drugs that are associated with Arteriosclerosis coronary artery:

Common conditions associated with Arteriosclerosis coronary artery:

All the conditions that are associated with Arteriosclerosis coronary artery:

How the study uses the data?

The study uses data from the FDA. It is based on omega-3acid ethyl esters (the active ingredients of Omacor) and Omacor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: